Most importantly, the cytolytic activity of 5T4p17-specific TCR transduced CD8+ T-cells was demonstrated with a panel of 5T4+/HLA-A2+ tumor targets including RCC, breast, and colon cancer tumor lines and primary RCC tumor in short-term culture. Here, CD8A is linked to neoplasm.